The following is a list of trial data that BioMedTracker will be covering at this year’s American Society of Hematology (ASH) annual meeting between December 10 and 13, 2005 in Atlanta. The trial data is broken down by indication and indicates whether the data is new or updated where available. Please note that the abstracts summarizing the trial data presented at ASH are available for review at the ASH website. We are prohibited from analyzing data until the actual presentations are made at ASH.

Acute Lymphocytic Leukemia (ALL)

Fodosine (BioCryst) – Abstract #881 12/10/05
New Phase II Data

Acute Myelogenous Leukemia (AML)

Dacogen (SuperGen) - Abstract #2515 12/11/2005
Updated Phase III Trial Data

Anaplastic Large Cell Lymphoma (ALCL)

SGN-30 (Seattle Genetics) Abstract #3356 12/12/2005
Updated Data from Phase II Refractory ALCL Trial

Chronic Lymphocytic Leukemia (CLL)

Genasense (Genta) Abstract #2129 12/11/2005
New Phase II Data for Trial in combination with Rituxan and Fludarabine

HuMax-CD20 (Medarex) Abstract #448 12/12/2005
Updated Phase I/II Data

Revlimid (Celgene) Abstract #447 12/12/2005
Updated Phase II Trial Data

Talabostat (Point Therapeutics) Abstract #2125 12/12/2005
Updated Phase II Trial Data

Chronic Myelogenous Leukemia (CML)

AG-858 (Antigenics) Abstract #1094 12/10/2005
New Phase II Data for Gleevec Refractory Trial

Dasatinib (Bristol-Myers Squibb) Abstract #42 12/11/2005
Data from Phase II START-L CA180015 Study

Cutaneous T-Cell Lymphoma (CTCL)

Ad-IFNgamma (Transgene) Abstract #1497 12/10/2005
Updated Data from Phase I/II Trial

Revlimid (Celgene) Abstract #3351 12/12/2005
New Phase II Data

Multiple Myeloma

Avastin (Genentech) Abstract #2571 12/11/2005
New Phase II Data

Revlimid (Celgene) Abstract #1565 12/10/2005
Updated Phase II Data from MM-014 Trial

Revlimid (Celgene) Abstract #3455 12/12/2005
New Thrombocytopenic Events Data from SWOG Trial

Thalomid (Celgene) Abstract #424 12/12/2005
Phase III Data from HOVON50/GMMG-HD3 Trial

Trisenox (Cephalon) Abstract #2564 12/11/2005
Updated Data from Phase II Trial

Myelodysplastic Syndrome (MDS)

Telintra (Telik) Abstract #2520 12/11/2005
Update from Phase II Trial

Myelofibrosis with Myeloid Metaplasia (MMM)

Revlimid (Celgene) Abstract #377 12/12/2005
Updated Phase II Trial Data

Non-Hodgkin's Lymphoma (NHL)

IMMU-106 (Immunomedics) Abstract #2428 12/11/2005
New Phase I/II Data

LY317615 (Eli Lilly) Abstract #934 12/10/2005
Phase II Trial Data

ONTAK (Ligand) Abstract #3349, 3350 12/12/2005
New Phase II Trial Data in B-Cell NHL in combination with Rituxan
Updated Phase II Trial Data in T-Cell NHL

Treanda (Cephalon) Abstract #923 12/10/2005
Updated Data from Phase II SDX-105-02 Trial

Treanda (Cephalon) Abstract #229 12/12/2005
Updated Data from Phase II SDX-105-01 Trial